References
- Martin-Llahi M, Pepin M-N, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology. 2008;134(5):1352–1359
- Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134(5):1360–1368
- Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279–1290
- Schrier RW, Niederberger M, Weigert A, Gines P. Peripheral arterial vasodilatation: Determinant of functional spectrum of cirrhosis. Semin Liver Dis. 1994;14(1):14–22
- Fabrizi F, Dixit V, Martin P. Meta-analysis: Terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther. 2006;24(6):935–944
- Gluud LL, Christensen K, Christensen E, Krag A. Terlipressin for hepatorenal syndrome. Cochrane Database Syst Rev. 2012;9:CD005162
- Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97(5):473–483
- Tiemann K, Becher H, Lohmeier S. Real-time assessment of tissue perfusion following bubble destruction at low emission-power – First experimental results using power pulse inversion imaging. J Am Coll Cardiol. 2000;35:426A
- Schneider AG, Hofmann L, Wuerzner G, et al. Renal perfusion evaluation with contrast-enhanced ultrasonography. Nephrol Dial Transplant. 2012;27(2):674–681
- Kishimoto N, Mori Y, Nishiue T, et al. Renal blood flow measurement with contrast-enhanced harmonic ultrasonography: Evaluation of dopamine-induced changes in renal cortical perfusion in humans. Clin Nephrol. 2003;59(6):423–428
- Schneider AG, Goodwin MD, Schelleman A, Bailey M, Johnson L, Bellomo R. Contrast-enhanced ultrasound to evaluate changes in renal cortical perfusion around cardiac surgery: A pilot study. Crit Care. 2013;17(4):R138
- Schneider A, Johnson L, Goodwin M, Schelleman A, Bellomo R. Bench-to-bedside review: Contrast enhanced ultrasonography – A promising technique to assess renal perfusion in the ICU. Crit Care. 2011;15(3):157
- Arditi M, Frinking PJ, Zhou X, Rognin NG. A new formalism for the quantification of tissue perfusion by the destruction–replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2006;53(6):1118–1129
- Nazar A, Pereira GH, Guevara M, et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2010;51(1):219–226
- Boyer TD, Sanyal AJ, Garcia-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics. J Hepatol. 2011;55(2):315–321